New yellow fever shot tested for safety in major trial
NCT ID NCT07002060
Summary
This study tested whether a new yellow fever vaccine called vYF is as safe as the currently licensed vaccine, YF-VAX. Researchers enrolled 640 healthy adults aged 18-60 and gave them a single shot of either the new or existing vaccine. They then monitored participants for six months to compare side effects like injection site reactions, fever, and headaches.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for YELLOW FEVER IMMUNIZATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
J. Lewis Research, Inc. / Foothill Family Clinic
Salt Lake City, Utah, 84109, United States
-
Johns Hopkins Bloomberg School of Public Health- Site Number : 8400009
Baltimore, Maryland, 21205, United States
-
Rochester Clinical Research- Site Number : 8400005
Rochester, New York, 14610, United States
-
Saint Louis University Center for Vaccine Development- Site Number : 8400001
St Louis, Missouri, 63104, United States
-
The Hope Clinic of Emory University- Site Number : 8400006
Decatur, Georgia, 30030, United States
-
Velocity Clinical Research - Providence- Site Number : 8400003
East Greenwich, Rhode Island, 02818, United States
-
Velocity Clinical Research-New Orleans- Site Number : 8400004
New Orleans, Louisiana, 70119, United States
Conditions
Explore the condition pages connected to this study.